About STRADEFY BIOSCIENCES, INC
Stradefy Biosciences is pioneering next-generation bioadhesive drug carriers (BDCs) for cellular bioadhesion, uptake, and therapeutic payload release, with lead candidates targeting oncology and immunology. The company is based in New Haven, CT, and was co-founded by Mark Saltzman, Michael Girardi, Yale University, and Elm Street Ventures.
Development of next-generation bioadhesive drug carriers (BDCs)Rational engineering for cellular bioadhesion, uptake, and therapeutic payload releaseIn vivo proof of efficacy in oncology modelsCapital-efficient path to proof of concept in targeted oncology
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to STRADEFY BIOSCIENCES, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.